Vomiting Illness Spreading Across Most of the United States

Wastewater monitoring stations across the United States are flashing the same signal: norovirus concentrations remain in the "HIGH category" based on samples collected over the past 21 days, according to WastewaterSCAN, one of the nation's largest sewage surveillance programs [1]. The virus — the leading cause of vomiting and diarrhea illness in the country — is circulating widely in late May 2026, well past the typical winter peak season.

But buried in the CDC's own genomic tracking data is a development that may matter more than raw case counts: the norovirus strain responsible for most of this illness is not the one public health authorities have tracked for over a decade. A genotype called GII.17 has staged a rapid, near-total takeover of the American norovirus landscape, and the implications for immunity, surveillance, and outbreak response are still being understood.

The Strain Shift: GII.17 Displaces a Decade of GII.4 Dominance

For years, GII.4 was the dominant norovirus genotype in the United States, responsible for roughly half of all genotyped outbreaks. That changed with striking speed. CaliciNet, the CDC's network of public health laboratories that performs norovirus outbreak genotyping, documented the shift in detail [2]:

• During the 2022–23 season, GII.17 accounted for just 7.5% of outbreaks, while GII.4 caused 48.9%.
• By 2023–24, GII.17 had surged to 34.3%, overtaking GII.4 (27.7%) by April 2024.
• In the 2024–25 season, GII.17 reached 75.4% of all genotyped outbreaks. GII.4 collapsed to 10.7% [2].

Source: CDC CaliciNet / Emerging Infectious Diseases

Data as of Apr 30, 2025CSV

The current GII.17 lineage likely descended from a strain that caused an outbreak in Romania in 2021, according to phylogenetic analysis of complete genome sequences deposited in GenBank [2]. The strain's mutations occur in regions that include the histo-blood group antigen-binding site — the molecular surface the virus uses to latch onto human cells — and putative antigenic epitopes, meaning the sites where human antibodies typically recognize and neutralize the virus [3].

This matters because prior population immunity, built up over years of GII.4 exposure, may offer reduced protection. As NBC News reported, GII.17 "partially evades prior immunity because people haven't been as exposed to it" [1]. The 2024–25 season also started earlier than historical norms, with peak activity in January rather than the typical February-March timeframe — a pattern researchers attributed to the new genotype's different seasonal dynamics [2].

By the Numbers: What CDC Surveillance Shows — and What It Misses

The CDC's NoroSTAT program, which aggregates outbreak data from 14 participating states, reported 1,194 norovirus outbreaks between August 1, 2025, and May 7, 2026. During the same window the previous seasonal year, those states reported 2,534 outbreaks [4]. The agency says the current total falls within the interquartile range — the middle 50% — of outbreak counts reported over the 2012–2025 period [4].

That framing has led the CDC to characterize national levels as not "unusually high" compared with prior seasons [1]. But several factors complicate that assessment.

First, NoroSTAT covers only 14 states: Colorado, Massachusetts, Michigan, Minnesota, Nebraska, New Hampshire, New Mexico, North Carolina, Ohio, Oregon, South Carolina, Tennessee, Virginia, and Wisconsin [4]. The remaining 36 states and territories are not included. Norovirus is not a nationally notifiable disease, meaning there is no federal requirement for states to report individual cases [5].

Second, most people who contract norovirus never see a doctor, and most who do are never tested. The CDC estimates norovirus causes approximately 21 million illnesses annually in the U.S., but the roughly 2,500 outbreaks reported each year represent only those clusters large or visible enough to trigger an investigation [6].

Third, wastewater surveillance — which detects the virus regardless of whether anyone seeks care — tells a different story than case-based reporting. WastewaterSCAN data shows persistent high concentrations across sampling sites in multiple regions, including Southern California, the San Francisco Bay Area, and the Northeast [1].

The Annual Toll: 900 Deaths, 109,000 Hospitalizations, and a $10.6 Billion Bill

Norovirus is often dismissed as a short-lived stomach bug. For most healthy adults, that characterization holds — symptoms typically resolve within one to three days. But the aggregate burden is substantial.

Source: CDC / Journal of Infectious Diseases

Data as of Jan 1, 2024CSV

Each year in the United States, norovirus causes an estimated 900 deaths — mostly among adults over 65 — along with 109,000 hospitalizations and 465,000 emergency department visits, with the youngest children bearing the highest rates of medical care visits [7]. Children under five have norovirus-associated hospitalization rates as high as 1,475 per 100,000 person-years in some studies [8]. Adults over 65, particularly those in long-term care facilities, face the highest mortality risk, and over half of all reported U.S. norovirus outbreaks occur in these settings [6][9].

The economic toll extends well beyond hospitals. Researchers estimated the total annual economic burden of norovirus in the United States at $10.6 billion [10]. A single symptomatic case costs a median of $48 in direct medical expenses and $416 in lost productivity, totaling $464 per episode. Productivity losses account for 89% of the total burden — the vast majority of the cost comes from missed work and school days, not medical bills [11]. Sporadic community illnesses, not headline-generating outbreaks, drive more than 90% of the annual cost [11].

For context, the $10.6 billion figure makes norovirus's economic footprint "higher than other diseases that have received far more attention," according to the study's authors [10]. And those estimates predate the current GII.17 strain shift, which may alter the burden profile if the new genotype causes more intense or widespread illness than its predecessor.

Why Your Hand Sanitizer Won't Help

One of the most persistent disconnects in public health messaging concerns alcohol-based hand sanitizers. During the COVID-19 pandemic, the use of hand sanitizer became deeply embedded in daily life. But norovirus is structurally different from SARS-CoV-2, and the same products that neutralize coronaviruses are largely ineffective against it.

The reason is the virus's protein shell, or capsid. Unlike enveloped viruses such as influenza or coronaviruses — which have a lipid membrane that alcohol dissolves — norovirus is a non-enveloped virus. Its capsid resists alcohol penetration, allowing the virus to survive exposure to standard hand sanitizers [12]. The CDC states explicitly: "Hand sanitizer alone does not work well against norovirus" [6].

A 2011 study published in the journal PLOS ONE found that long-term care facilities where staff used hand sanitizers as the primary hand-hygiene method experienced higher rates of norovirus outbreaks compared to facilities relying on soap and water [13]. The mechanism is straightforward: hand sanitizer gives a false sense of protection, potentially reducing the frequency of actual handwashing.

"Washing hands with soap and water is the gold standard for preventing a norovirus infection," researchers at Penn State noted. "Unlike hand sanitizers, proper handwashing creates friction that removes the virus particles from your skin" [14]. The CDC recommends scrubbing with soap and water for at least 20 seconds [6].

Surface disinfection presents a parallel challenge. Standard household cleaners may not inactivate norovirus on contaminated surfaces. The CDC recommends bleach-based solutions or EPA-registered products specifically tested against norovirus [6]. Whether these recommendations are reaching the public effectively is another matter — years of pandemic-era hand sanitizer promotion left many Americans with the assumption that alcohol-based products provide universal viral protection [12].

Surveillance Gaps: A System Not Designed for This Virus

The United States has no unified national norovirus surveillance system. What exists is a patchwork.

NoroSTAT combines data from 14 voluntary state participants. CaliciNet tracks genotypes from outbreak specimens submitted to its laboratory network. The National Respiratory and Enteric Virus Surveillance System (NREVSS) collects testing data from clinical laboratories. And wastewater surveillance programs like WastewaterSCAN operate independently, funded through a mix of federal grants and academic partnerships [5].

None of these systems talk to each other in real time. Reporting lags can stretch weeks — a meaningful delay for a virus with a 12-to-48-hour incubation period that can spread to seven or more people per infected individual [1][5]. California, one of the most populous states, has a "paucity of NREVSS data with average total reported monthly specimens less than 10," according to researchers who studied wastewater-based surveillance as an alternative [5].

The structural problem is that norovirus reporting is voluntary at every level. There is no federal mandate for states to report individual cases. School reporting requirements vary by district and state. Restaurant inspection protocols differ across thousands of local health jurisdictions. This fragmentation means multi-state outbreaks can build to significant scale before any centralized authority has a complete picture [5][6].

Wastewater surveillance has emerged as a partial solution, capable of detecting norovirus trends regardless of clinical testing behavior. But as of 2026, it remains supplementary — useful for identifying trends, but not integrated into the formal outbreak alert and response infrastructure the way clinical case reporting is [5].

High-Transmission Settings: Cruise Ships, Care Facilities, and Shared Kitchens

Norovirus outbreaks cluster in environments where people share close quarters, meals, and facilities. The CDC's Vessel Sanitation Program has tracked 214 norovirus outbreaks on cruise ships between 2006 and 2026, making it the most commonly reported pathogen in that setting [15]. In 2025 alone, cruise ship disease outbreaks hit 23, with norovirus as the most common cause [16].

But cruise ships, while high-profile, account for a small fraction of total outbreaks. Long-term care facilities bear a disproportionate burden: over half of all reported U.S. norovirus outbreaks occur in nursing homes and similar residential care settings [9]. The virus enters through infected patients, staff, visitors, or contaminated food, and outbreaks in these closed environments can persist for months [17]. States including Minnesota and Maine issued specific norovirus outbreak prevention toolkits for long-term care facilities ahead of the 2025–26 season [9].

Food supply chains represent another transmission vector. Norovirus is the leading cause of foodborne illness in the United States, often linked to infected food handlers who prepare meals while symptomatic or shortly after recovery — the virus can shed in stool for up to two weeks after symptoms resolve [1][6]. Contaminated produce, particularly leafy greens and shellfish, has been implicated in past multi-state outbreaks.

The Skeptic's Case: Is This Really Abnormal?

The CDC's own data provides the strongest counterargument to alarm: 1,194 outbreaks reported through May 2026 is within normal historical range, and substantially below the 2,534 reported during the same period last year [4]. Norovirus circulates every year. It peaks every winter. It has always been widespread.

Several factors may amplify the perception of a worse-than-usual season. The GII.17 strain shift has drawn significant media and scientific attention — over 16,100 academic papers on norovirus outbreaks have been published since 2011, with research peaking at 1,727 papers in 2023 during heightened post-pandemic interest in enteric viruses [18].

Source: OpenAlex

Data as of Jan 1, 2026CSV

Wastewater surveillance, which expanded dramatically during the COVID-19 pandemic, now detects norovirus at a resolution that simply did not exist five years ago. Higher detection does not necessarily mean higher transmission — it may partly reflect better measurement of something that was always there [5].

Reporting awareness also matters. When media outlets publish stories about a "vomiting virus spreading across most of the U.S.," clinicians and public health officials may increase testing, patients may be more likely to seek care, and state agencies may submit more specimens to CaliciNet — all of which inflate reported numbers without any change in actual viral prevalence.

None of this means the outbreak is fabricated or unimportant. The strain shift to GII.17 is real and virologically significant. The high wastewater levels are genuine measurements. And the populations most vulnerable to norovirus — young children, elderly nursing home residents, and immunocompromised patients — face real health risks each season. The question is whether the current season represents an anomalous surge or the normal seasonal cycle observed through better instrumentation and heightened attention.

What Happens If This Extends Through Summer

Norovirus activity typically declines after April, but the May 2026 wastewater data suggests continued circulation. If transmission persists at elevated levels into summer, several cascading effects are plausible.

Healthcare facilities face staffing challenges when norovirus circulates among workers. A cross-sectional study of nosocomial outbreaks found that healthcare workers are frequently infected during facility outbreaks, with risk factors including direct patient contact and inadequate hand hygiene [17]. Widespread staff illness can force postponement of elective procedures — not because patients are sick, but because there aren't enough healthy workers to operate.

Summer camps, festivals, and other mass-gathering events present concentrated transmission risks similar to cruise ships. Children under five, already the age group with the highest medical care utilization from norovirus, would be at particular risk in camp settings with shared dining and dormitory-style housing [7].

Local health departments — many of which have not fully recovered staffing levels lost during the COVID-19 pandemic — would face additional strain. Contact tracing and source investigations for norovirus outbreaks are labor-intensive, and departments already stretched thin by routine communicable disease work may lack capacity for the kind of rapid, thorough outbreak responses that limit spread [17].

Rotavirus, a separate but symptomatically similar virus, is also circulating at rates higher than the same period last year, and declining childhood vaccination rates have raised concerns about more severe illness in that channel as well [19]. The convergence of two gastrointestinal viruses during a period when health department capacity is constrained presents a compounding challenge.

The Bigger Picture

The GII.17 strain shift represents the most significant change in the American norovirus landscape in over a decade — the kind of genotype displacement that last occurred when GII.4 Sydney emerged in 2012. Whether it produces a genuinely worse season or simply a different one depends on factors that epidemiologists are still measuring: the extent of cross-protective immunity from prior GII.4 exposure, the severity profile of GII.17 infections compared to GII.4, and whether the new strain's seasonality follows the same winter-peaking pattern or establishes a different rhythm.

What is already clear is that the surveillance infrastructure designed to track norovirus in the United States — voluntary reporting, 14-state participation, weeks-long data lags — was built for a different era. Wastewater monitoring has shown what more comprehensive, population-level tracking can look like. Whether that capacity gets formalized and funded, or remains a pandemic-era experiment that slowly loses support, may determine how quickly the country sees the next significant norovirus shift coming.